Access to Breast Cancer Diagnosis Act of 2025
Official title: To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance… Show full official titleShow less
Official title: To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House Formatted Text PDF Formatted XML
- NOVARTIS
- GE HEALTHCARE TECHNOLOGIES INC.
- FORBES-TATE
- AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.
- ARTEMIS POLICY GROUP LLC
- HADASSAH, THE WOMEN'S ZIONIST ORGANIZATION OF AMERICA, INC.
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Health & Human Services, Dept of (HHS)
- Centers For Medicare and Medicaid Services (CMS)
- Office of Management & Budget (OMB)
- Food & Drug Administration (FDA)
- Treasury, Dept of
- Commerce, Dept of (DOC)
Cite this page
U.S. Congress. (2026). H.R. 3037: Access to Breast Cancer Diagnosis Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-3037/
"H.R. 3037: Access to Breast Cancer Diagnosis Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-3037/.
H.R. 3037, 119th Cong. (2026), https://openamerica.io/bill/119-HR-3037/.
[H.R. 3037: Access to Breast Cancer Diagnosis Act of 2025](https://openamerica.io/bill/119-HR-3037/)